These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29912308)

  • 1. Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.
    van der Velden J; Tocchetti CG; Varricchi G; Bianco A; Sequeira V; Hilfiker-Kleiner D; Hamdani N; Leite-Moreira AF; Mayr M; Falcão-Pires I; Thum T; Dawson DK; Balligand JL; Heymans S
    Cardiovasc Res; 2018 Aug; 114(10):1273-1280. PubMed ID: 29912308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.
    Bondue A; Arbustini E; Bianco A; Ciccarelli M; Dawson D; De Rosa M; Hamdani N; Hilfiker-Kleiner D; Meder B; Leite-Moreira AF; Thum T; Tocchetti CG; Varricchi G; Van der Velden J; Walsh R; Heymans S
    Cardiovasc Res; 2018 Aug; 114(10):1287-1303. PubMed ID: 29800419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With Hypertrophic Cardiomyopathy.
    Nollet EE; Schuldt M; Sequeira V; Binek A; Pham TV; Schoonvelde SAC; Jansen M; Schomakers BV; van Weeghel M; Vaz FM; Houtkooper RH; Van Eyk JE; Jimenez CR; Michels M; Bedi KC; Margulies KB; Dos Remedios CG; Kuster DWD; van der Velden J
    Circ Genom Precis Med; 2024 Jun; 17(3):e004369. PubMed ID: 38853772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic cardiomyopathy.
    Ho CY
    Heart Fail Clin; 2010 Apr; 6(2):141-59. PubMed ID: 20347784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
    Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies.
    Yotti R; Seidman CE; Seidman JG
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():129-153. PubMed ID: 30978303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.
    Ramachandra CJA; Chua J; Cong S; Kp MMJ; Shim W; Wu JC; Hausenloy DJ
    Cardiovasc Res; 2021 Feb; 117(3):694-711. PubMed ID: 32365198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial Deformation Analysis in
    Höller V; Seebacher H; Zach D; Schwegel N; Ablasser K; Kolesnik E; Gollmer J; Waltl G; Rainer PP; Verheyen S; Zirlik A; Verheyen N
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcomeres and Cardiac Growth: Tension in the Relationship.
    Haldar SM; Srivastava D
    Trends Mol Med; 2016 Jul; 22(7):530-533. PubMed ID: 27237981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hereditary cardiomyopathies: a review. Mutation of structural proteins a common cause of hereditary cardiomyopathy].
    Sjöberg G; Kostareva A; Sejersen T
    Lakartidningen; 2005 Mar 14-20; 102(11):845-7, 850-3. PubMed ID: 15835520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC).
    de Boer RA; Heymans S; Backs J; Carrier L; Coats AJS; Dimmeler S; Eschenhagen T; Filippatos G; Gepstein L; Hulot JS; Knöll R; Kupatt C; Linke WA; Seidman CE; Tocchetti CG; van der Velden J; Walsh R; Seferovic PM; Thum T
    Eur J Heart Fail; 2022 Mar; 24(3):406-420. PubMed ID: 34969177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative Potential of Cardiomyocytes in Hypertrophic Cardiomyopathy: Correlation with Myocardial Remodeling.
    Sukhacheva TV; Chudinovskikh YA; Eremeeva MV; Serov RA; Bockeria LA
    Bull Exp Biol Med; 2016 Nov; 162(1):160-169. PubMed ID: 27882462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical and energetic consequences of HCM-causing mutations.
    Ferrantini C; Belus A; Piroddi N; Scellini B; Tesi C; Poggesi C
    J Cardiovasc Transl Res; 2009 Dec; 2(4):441-51. PubMed ID: 20560002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertrophic cardiomyopathy].
    Bundgaard H; Havndrup O; Høst U; Kelbaek H
    Ugeskr Laeger; 1998 Sep; 160(38):5478-83. PubMed ID: 9763919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular targets and novel pharmacological options to prevent myocardial hypertrophic remodeling].
    Coppini R; Ferrantini C; Poggesi C; Mugelli A; Olivotto I
    G Ital Cardiol (Rome); 2016 Mar; 17(3):189-96. PubMed ID: 27029877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome dysfunction in cardiomyopathies.
    Gilda JE; Gomes AV
    J Physiol; 2017 Jun; 595(12):4051-4071. PubMed ID: 28181243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy.
    Luedde M; Flögel U; Knorr M; Grundt C; Hippe HJ; Brors B; Frank D; Haselmann U; Antony C; Voelkers M; Schrader J; Most P; Lemmer B; Katus HA; Frey N
    J Mol Med (Berl); 2009 Apr; 87(4):411-22. PubMed ID: 19189074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between cardiac myosin-binding protein C and formin Fhod3.
    Matsuyama S; Kage Y; Fujimoto N; Ushijima T; Tsuruda T; Kitamura K; Shiose A; Asada Y; Sumimoto H; Takeya R
    Proc Natl Acad Sci U S A; 2018 May; 115(19):E4386-E4395. PubMed ID: 29686099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
    Ashrafian H; Redwood C; Blair E; Watkins H
    Trends Genet; 2003 May; 19(5):263-8. PubMed ID: 12711218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation-specific pathology and treatment of hypertrophic cardiomyopathy in patients, mouse models and human engineered heart tissue.
    Wijnker PJM; van der Velden J
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165774. PubMed ID: 32217077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.